Rankia España Rankia Argentina Rankia Brasil Rankia Chile Rankia Colombia Rankia Czechia Rankia Deutschland Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia México Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom Rankia USA
Acceder

Paragon Care (PGC)

33 respuestas
Paragon Care (PGC)
1 suscriptores
Paragon Care (PGC)
Página
2 / 3
#17

Re: Paragon Care (PGC)

Infravalorada, valor intrínseco 1,35. Cotiza a 93c

 

 

 

Should You Buy Paragon Care Limited (ASX:PGC)?

Paragon Care Limited ( ASX:PGC), a healthcare equipment and services company based in Australia, led the ASX gainers with a relatively large price hike in the past couple of weeks. Less covered, small-stocks like PGC sees more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could PGC still be trading at a low price relative to its actual value? Let’s examine PGC’s valuation and outlook in more detail to determine if there’s still a bargain opportunity. View our latest analysis for Paragon Care

 

Is PGC still cheap?

Great news for investors – PGC is still trading at a fairly cheap price. According to my valuation, the intrinsic value for the stock is $1.36 which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. PGC’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach its true value, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.

 

 

What kind of growth will PGC generate?

ASX:PGC Future Profit Sep 19th 17
ASX:PGC Future Profit Sep 19th 17
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio.Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at PGC future expectations. With profit expected to grow by 38.24% over the next couple of years, the future seems bright for PGC. It looks like higher cash flows is on the cards for the stock, which should feed into a higher share valuation.

 

What this means for you:

 

Are you a shareholder? Since PGC is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on PGC for a while, now might be the time to make a leap. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy PGC. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Paragon Care. You can find everything you need to know about PGC in the latest infographic research report. If you are no longer interested in Paragon Care, you can use our fr

Should You Buy Paragon Care Limited (ASX:PGC)?

Paragon Care Limited ( ASX:PGC), a healthcare equipment and services company based in Australia, led the ASX gainers with a relatively large price hike in the past couple of weeks. Less covered, small-stocks like PGC sees more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could PGC still be trading at a low price relative to its actual value? Let’s examine PGC’s valuation and outlook in more detail to determine if there’s still a bargain opportunity. View our latest analysis for Paragon Care

 

Is PGC still cheap?

Great news for investors – PGC is still trading at a fairly cheap price. According to my valuation, the intrinsic value for the stock is $1.36 which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. PGC’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach its true value, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.

 

 

What kind of growth will PGC generate?

ASX:PGC Future Profit Sep 19th 17
ASX:PGC Future Profit Sep 19th 17
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio.Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at PGC future expectations. With profit expected to grow by 38.24% over the next couple of years, the future seems bright for PGC. It looks like higher cash flows is on the cards for the stock, which should feed into a higher share valuation.

 

What this means for you:

 

Are you a shareholder? Since PGC is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on PGC for a while, now might be the time to make a leap. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy PGC. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Paragon Care. You can find everything you need to know about PGC in the latest infographic research report. If you are no longer interested in Paragon Care, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

Daniel Loeb has achieved 16.2% annualized returns over the last 20 years. What is he holding today?

Founder of the event-driven, value-oriented hedge fund Third Point, Daniel Loeb is one of the most successful activist investors on the market today. Explore his portfolio’s top holdings, see how he diversifies his investments, past performance and growth estimates. Click here to view a FREE detailed infographic analysis of Daniel Loeb’s investment portfolio.

ee platform to see my list of over 50 other stocks with a high growth potential.

Daniel Loeb has achieved 16.2% annualized returns over the last 20 years. What is he holding today?

Founder of the event-driven, value-oriented hedge fund Third Point, Daniel Loeb is one of the most successful activist investors on the market today. Explore his portfolio’s top holdings, see how he diversifies his investments, past performance and growth estimates. Click here to view a FREE detailed infographic analysis of Daniel Loeb’s investment portfolio.
#19

Re: Paragon Care (PGC)

Está corregida, pero alcista de medio y largo plazo

 

 

Paragon Care Ltd. Technical Analysis Chart | 4-Traders

#22

Re: Paragon Care (PGC)

Buen cierre, 3,9% arriba

#24

Re: Paragon Care (PGC)

Ya está en 82c, subiendo buscando los máximos

#27

Re: Paragon Care (PGC)

Paragon Care Ltd (ASX: PGC)

Paragon is a small cap healthcare business that provides equipment, devices and other items to aged care facilities, hospitals and other healthcare providers.

It is steadily acquiring more healthcare businesses so that it can supply more of the needs of its clients. Hopefully growing in size through acquisitions will lead to bigger economies of scale.

The ageing tailwinds of Australia and New Zealand will likely lead to growing earnings over time.

It’s currently trading at 15x FY18’s estimated earnings.

https://www.fool.com.au/2018/05/24/3-small-caps-with-big-potential/

#28

Re: Paragon Care (PGC)

Pendientes de nueva adquisición

 

Paragon Care has a new asset in its sights

Share 

11:30 06 Jun 2018

Paragon has been acquiring businesses in the healthcare sector.

Paragon Care has a new asset in its sights

The company's shares are in pre-open

Paragon Care Ltd ( ASX:PGC) is back on the acquisition trail, with the ASX granting the company a trading halt this morning pending its next bolt on.

Earlier in the year Paragon outlined nine acquisition opportunities in the healthcare sector during the company's $69.8 million capital raising.

 

Seven of these have been completed so far.

Paragon is also set for a busy June quarter, as historically over a third of the year’s business has normally been transacted during this period.

The company is a provider of medical equipment, devices and consumables for the Australian and New Zealand healthcare market.

The halt will remain in place until the opening of trade on Friday 8 June 2018, or earlier if an announcement is made to the market.

 

Share 

#29

Re: Paragon Care (PGC)

Adquieren Rem Systems, sube un 4%

 

Should you buy Paragon Care Ltd. (ASX:PGC) after its acquisition spree?

Tommaso Autorino | June 8, 2018 |  More on:  PGC

Shares in  Paragon Care Ltd  (ASX: PGC) rose 3% to $0.84c on Friday morning’s trade, after the company announced the acquisition of New Zealand-based healthcare business  REM Systems for a net enterprise value of NZ$54 million (about $50 million).

The details of the transaction

Paragon will settle 80% of the purchase in cash and the rest through the issuance of 12.7 million shares at the 30-day volume-weighted average price of $0.76c. In addition, the deal includes earn-out provision of 4.5 times FY20 and FY21 incremental EBITDA from the acquisition. REM’s vendors and executive management will stay with the business throughout the earn-out period.

REM has a forecast FY18 revenue base of NZ$68 million and EBITDA of NZ$7 million.

Funding for the transaction derives partly from Paragon’s recent $70 million capital raising and partly from an increased debt facility with  National Australia Bank  (ASX: NAB). Paragon’s net debt to EBITDA ratio is expected to be between 2x and 2.5x following the acquisition.

Strategic rationale

Paragon’s Chairman, Shane Tanner, described REM as a “near perfect strategic fit”.

Through a series of acquisitions of suppliers of the healthcare sector – seven in the last four months –Paragon has grown to become an integrated healthcare equipment and services provider for acute, aged and primary care in Australia and New Zealand.

The acquisition of REM is particularly significant given the size of the target – in comparison with Paragon’s market capitalisation of $230 million – and the fact that REM itself is a diversified medical distribution company supplying 4,000 customers including acute care hospitals, day surgeries, medical practices and veterinary clinics throughout New Zealand and Australia, with an articulate structure that resembles Paragon’s.

Despite its strong organic growth – in the range of 6% to 8% per annum over recent years, according to Paragon’s announcement – REM is still a family run business

The acquisition is anticipated to be in excess of 10% EPS accretive in FY19 and beyond.

Foolish takeaway

I’m usually quite wary of growth built on an acquisition spree, but in this case I think the move makes perfect sense, given the homogeneity between Paragon and REM.

Based on the company’s forecast, the stock trades at just 11x FY18 earnings. With this valuation, I think Paragon is a good option to gain exposure to the healthcare sector, which is poised to grow in coming years as the Australian population ages.

But there’s another industry ready to take off.  Click here to claim your free report.

7 of 8 People Are Clueless About This Trillion-Dollar Market

One of our investors has recently returned from a research trip to Silicon Valley... and has a warning for fellow investors:

Because he works for an organization dedicated to spreading great investing ideas, his video report is free today... so you can see it and decide for yourself.

Don't miss your chance  click here to learn about this warning and how you might be able to profit!

Motley Fool contributor  Tommaso Autorino has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of National Australia Bank Limited. The Motley Fool Australia has recommended Paragon Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a  diverse range of insights makes us better investors. The Motley Fool has a  disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

#30

Re: Paragon Care (PGC)

Para arriba de nuevo, buena adquisición para seguir creciendo

Brokers destacados